United Kingdom


The Hewett Building
14 Hewett Street
London, EC2A3NP
Phone: (+44) 208 159 3593
Email: enquiries@organon.com

Organon products

Contact us banner image
To report an adverse event (AE) for an Organon product please contact:

Adverse events reporting

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple Store. Adverse events should also reported to Organon Pharma (UK) Limited. ( Tel: 02081 593593 ). By clicking the above link you will leave the Organon website and be taken to the MHRA website

Contact us banner image
Great Britain

Medical Information

Contact us banner image
Northern Ireland

Medical Information


Privacy Notice for Adverse Events, Medical Information Inquiries and Suspected Product Quality Complaints

Product supply updates

Ensuring continuity of supply of medicines for patients is Organon’s highest priority.

This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Organon Pharma (UK) Limited, company number 820771

Product DescriptionSupply StatusEstimated Resupply Date

Asmanex® Twisthaler® 200 micrograms Inhalation Powder

Out of Stock

Q2 2022

Innovace® 2.5mg Tablets

Intermittent Supply

October/November 2021

Innovace® 5mg Tablets

Intermittent Supply

Q4 2021

Innozide® 20/12.5 mg Tablets

Out of Stock

November 2021

Counterfeit Medicines

At Organon we take the safety of our patients extremely seriously and work with governments and customs authorities around the world to help control the problems caused by counterfeit medicines.

For more information about counterfeit medicines please visit: gov.uk/mhra

For all medical enquiries about Organon products please contact us.

Modern slavery, Gender Pay Gap, UK Tax Strategy

Up until 2 June 2021, Organon Pharma (UK) Limited was affiliated to Merck & Co., Inc. of Kenilworth, New Jersey, US and its compliance statements in the UK, as it applies to the Modern Slavery Act, its UK Tax Strategy and Gender Pay Gap, was co-reported for 2020 with Merck Sharp & Dohme (UK) Limited. Details of Organon Pharma (UK) Limited’s compliance with these provisions can be found at: www.msd-uk.com

UK Partnerships

Liverpool improving access to long acting reversible contraception project

Terms of use

Date of preparation: November 2021. Job code: GB-NON-110230